{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fa16z.simplecast.com%2Fepisodes%2Fthe-science-and-supply-of-glp-1s-xlszRiU1","width":444,"version":"1.0","type":"rich","title":"The Science and Supply of GLP-1s","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/0d97354a-306b-45f5-bf26-a8d81eef47ec/ed2664df-9371-438e-8baf-dd2ee0fdde87/thea16zshow-podcastcoverart-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ad5eb82e-338a-48eb-8997-f84b66995e51\" height=\"200\" width=\"100%\" title=\"The Science and Supply of GLP-1s\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.\n\nTogether, they talk about the value of obesity medicine practitioners, patient-centric medical homes, and how Brooke believes the metabolic health space will evolve over time.\n\nThis is the second episode in Raising Health’s series on the science and supply of GLP-1s. Listen to last week's episode to hear from Carolyn Jasik, Chief Medical Officer at Omada Health, on GLP-1s from a clinical perspective."}